نتایج جستجو برای: pipobromane anticancer drug

تعداد نتایج: 613496  

Journal: :Chemical communications 2015
Soyeon Park Eunjin Kim Won Young Kim Chulhun Kang Jong Seung Kim

A novel biotin-guided anticancer drug delivery system, prodrug , consisting of biotin, nitrobenzene, and doxorubicin, with acid-triggered drug releasing capability was synthesized. Its cellular uptake and anticancer activity are selective to the HepG2 cell line over the WI-38 cell line, as revealed by fluorescence confocal microscopic experiments and MTT assay.

2016
Zhi-Gang Jiang Steven A. Fuller Hossein A. Ghanbari

Chemotherapy often results in cognitive impairment, and no neuroprotective drug is now available. This study aimed to understand underlying neurotoxicological mechanisms of anticancer drugs and to evaluate neuroprotective effects of PAN-811. Primary neurons in different concentrations of antioxidants (AOs) were insulted for 3 days with methotrexate (MTX), 5-fluorouracil (5-FU), or cisplatin (CD...

Journal: :Future Journal of Pharmaceutical Sciences 2021

Abstract Background The heterocyclic compounds particularly pyridine displayed clinical and biological implementation. Pyridine scaffolds have been detected in most relevant drug molecules that included provided a great possibility for treatment. Main text Pyridine-containing increasing importance medicinal application as antiviral, anticholinesterase activities, antimalarial, antimicrobial, an...

Journal: :Neuro-oncology 2015
Victor A Levin Peter J Tonge James M Gallo Marc R Birtwistle Arvin C Dar Antonio Iavarone Patrick J Paddison Timothy P Heffron William F Elmquist Jean E Lachowicz Ted W Johnson Forest M White Joohee Sul Quentin R Smith Wang Shen Jann N Sarkaria Ramakrishna Samala Patrick Y Wen Donald A Berry Russell C Petter

Following the first CNS Anticancer Drug Discovery and Development Conference, the speakers from the first 4 sessions and organizers of the conference created this White Paper hoping to stimulate more and better CNS anticancer drug discovery and development. The first part of the White Paper reviews, comments, and, in some cases, expands on the 4 session areas critical to new drug development: p...

Journal: :Journal of chemical information and modeling 2014
Fidele Ntie-Kang Justina Ngozi Nwodo Akachukwu Ibezim Conrad Veranso Simoben Berin Karaman Valery Fuh Ngwa Wolfgang Sippl Michael Umale Adikwu Luc Meva'a Mbaze

Naturally occurring anticancer compounds represent about half of the chemotherapeutic drugs which have been put in the market against cancer until date. Computer-based or in silico virtual screening methods are often used in lead/hit discovery protocols. In this study, the "drug-likeness" of ~400 compounds from African medicinal plants that have shown in vitro and/or in vivo anticancer, cytotox...

2015
Takanori Goi Takayuki Naruse Youhei Kimura Daisuke Fujimoto Mitsuhiro Morikawa Kenji Koneri Akio Yamaguchi

BACKGROUND Systemic FOLFOX (folinic acid (leucovorin (LV)), 5-fluorouracil (5-FU), and oxaliplatin), FOLFIRI (LV, 5-FU, and irinotecan), or FOLFOXIRI (5-FU, leucovorin, oxaliplatin, and irinotecan) chemotherapy regimens and additional molecular-target treatments, including anti-vascular endothelial growth factor, anti-epidermal growth factor receptor, and anti-multi-kinase antibodies, have been...

2016
Tomoyuki Okabe Takeharu Ogura Takashi Yoshimura Yoshiyuki Tanaka Hiromu Toyoda Ken-ichi Fujita Yasutsuna Sasaki

The generic anticancer drugs are developed in the field of anticancer therapy and are commercially available. Generally, the safety and efficacy of a brand anticancer drug are determined by phase 1, 2 and 3 clinical trials. In contrast, clinical trials are not necessarily required by guidelines for the development of generic drugs and are usually not performed. Pharmacokinetic equivalence is co...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید